Panagora Asset Management Inc. grew its position in shares of Maximus, Inc. (NYSE:MMS – Free Report) by 4.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 272,275 shares of the health services provider’s stock after acquiring an additional 11,525 shares during the period. Panagora Asset Management Inc.’s holdings in Maximus were worth $23,503,000 at the end of the most recent reporting period.
Several other institutional investors have also recently modified their holdings of the company. JPMorgan Chase & Co. grew its position in Maximus by 19.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 200,331 shares of the health services provider’s stock worth $18,304,000 after acquiring an additional 33,136 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Maximus by 2.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider’s stock worth $170,812,000 after acquiring an additional 36,989 shares during the last quarter. Divisadero Street Capital Management LP grew its position in Maximus by 93.5% during the 3rd quarter. Divisadero Street Capital Management LP now owns 183,872 shares of the health services provider’s stock worth $16,800,000 after acquiring an additional 88,872 shares during the last quarter. WINTON GROUP Ltd bought a new position in Maximus during the 3rd quarter worth approximately $6,208,000. Finally, Assenagon Asset Management S.A. bought a new position in Maximus during the 4th quarter worth approximately $15,673,000. 97.21% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on MMS shares. Wall Street Zen upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Zacks Research lowered Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Weiss Ratings lowered Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.
Maximus Trading Down 1.8%
NYSE MMS opened at $61.19 on Tuesday. Maximus, Inc. has a fifty-two week low of $56.92 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.21 and a current ratio of 2.21. The stock has a 50 day simple moving average of $63.44 and a two-hundred day simple moving average of $75.68. The stock has a market cap of $3.21 billion, a P/E ratio of 9.16 and a beta of 0.58.
Maximus (NYSE:MMS – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The health services provider reported $2.07 earnings per share for the quarter, topping the consensus estimate of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The business had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter last year, the business posted $2.01 EPS. The business’s revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, analysts forecast that Maximus, Inc. will post 8.43 earnings per share for the current year.
Maximus Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, June 1st. Stockholders of record on Friday, May 15th were paid a $0.33 dividend. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date was Friday, May 15th. Maximus’s dividend payout ratio (DPR) is presently 19.76%.
About Maximus
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
See Also
- Five stocks we like better than Maximus
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
